Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Total Current Liabilities: 2022-2024

Historic Total Current Liabilities for Orchestra BioMed Holdings (OBIO) over the last 3 years, with Dec 2024 value amounting to $16.2 million.

  • Orchestra BioMed Holdings' Total Current Liabilities rose 27.36% to $20.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year increase of 27.36%. This contributed to the annual value of $16.2 million for FY2024, which is 44.60% up from last year.
  • According to the latest figures from FY2024, Orchestra BioMed Holdings' Total Current Liabilities is $16.2 million, which was up 44.60% from $11.2 million recorded in FY2023.
  • Orchestra BioMed Holdings' 5-year Total Current Liabilities high stood at $18.6 million for FY2022, and its period low was $11.2 million during FY2023.
  • For the 3-year period, Orchestra BioMed Holdings' Total Current Liabilities averaged around $15.3 million, with its median value being $16.2 million (2024).
  • In the last 5 years, Orchestra BioMed Holdings' Total Current Liabilities plummeted by 39.63% in 2023 and then soared by 44.60% in 2024.
  • Over the past 3 years, Orchestra BioMed Holdings' Total Current Liabilities (Yearly) stood at $18.6 million in 2022, then tumbled by 39.63% to $11.2 million in 2023, then soared by 44.60% to $16.2 million in 2024.